Search Page

1

Cite

Share

Tolerability and safety of perampanel: two randomized dose-escalation studies.

Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, Squillacote D, Kumar D. Krauss GL, et al. Among authors: squillacote d. Acta Neurol Scand. 2012 Jan;125(1):8-15. doi: 10.1111/j.1600-0404.2011.01588.x. Epub 2011 Aug 29. Acta Neurol Scand. 2012. PMID: 21883097 Clinical Trial.

Cite

Share

2

Cite

Share

Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.

Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Lees A, et al. Among authors: squillacote d. Mov Disord. 2012 Feb;27(2):284-8. doi: 10.1002/mds.23983. Epub 2011 Dec 9. Mov Disord. 2012. PMID: 22161845 Clinical Trial.

Cite

Share

3

Cite

Share

Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy.

Sperling MR, Haas KF, Krauss G, Seif Eddeine H, Henney HR 3rd, Rabinowicz AL, Bream G, Squillacote D, Carrazana EJ. Sperling MR, et al. Among authors: squillacote d. Epilepsia. 2014 Oct;55(10):1544-50. doi: 10.1111/epi.12755. Epub 2014 Aug 25. Epilepsia. 2014. PMID: 25154625 Free article. Clinical Trial.

Cite

Share

4

Cite

Share

Perampanel Study 207: long-term open-label evaluation in patients with epilepsy.

Rektor I, Krauss GL, Bar M, Biton V, Klapper JA, Vaiciene-Magistris N, Kuba R, Squillacote D, Gee M, Kumar D. Rektor I, et al. Among authors: squillacote d. Acta Neurol Scand. 2012 Oct;126(4):263-9. doi: 10.1111/ane.12001. Epub 2012 Aug 23. Acta Neurol Scand. 2012. PMID: 22913800 Clinical Trial.

Cite

Share

5

Cite

Share

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.

French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA. French JA, et al. Among authors: squillacote d. Neurology. 2012 Aug 7;79(6):589-96. doi: 10.1212/WNL.0b013e3182635735. Epub 2012 Jul 25. Neurology. 2012. PMID: 22843280 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.

Krauss GL, Serratosa JM, Villanueva V, Endziniene M, Hong Z, French J, Yang H, Squillacote D, Edwards HB, Zhu J, Laurenza A. Krauss GL, et al. Among authors: squillacote d. Neurology. 2012 May 1;78(18):1408-15. doi: 10.1212/WNL.0b013e318254473a. Epub 2012 Apr 18. Neurology. 2012. PMID: 22517103 Clinical Trial.

Cite

Share

7

Cite

Share

Doctor discontent.

Squillacote DC. Squillacote DC. N Engl J Med. 1999 Feb 25;340(8):650; author reply 652-3. N Engl J Med. 1999. PMID: 10049078 No abstract available.

Cite

Share

8

Cite

Share

Perampanel for adjunctive treatment of partial-onset seizures: a pooled dose-response analysis of phase III studies.

Kramer LD, Satlin A, Krauss GL, French J, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Laurenza A, Yang H, Zhu J, Squillacote D. Kramer LD, et al. Among authors: squillacote d. Epilepsia. 2014 Mar;55(3):423-31. doi: 10.1111/epi.12527. Epub 2014 Mar 7. Epilepsia. 2014. PMID: 24605793 Free article. Clinical Trial.

Cite

Share

9

Cite

Share

Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.

Rascol O, Barone P, Behari M, Emre M, Giladi N, Olanow CW, Ruzicka E, Bibbiani F, Squillacote D, Patten A, Tolosa E. Rascol O, et al. Among authors: squillacote d. Clin Neuropharmacol. 2012 Jan-Feb;35(1):15-20. doi: 10.1097/WNF.0b013e318241520b. Clin Neuropharmacol. 2012. PMID: 22222634 Clinical Trial.

Cite

Share

10

Cite

Share

Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.

Eggert K, Squillacote D, Barone P, Dodel R, Katzenschlager R, Emre M, Lees AJ, Rascol O, Poewe W, Tolosa E, Trenkwalder C, Onofrj M, Stocchi F, Nappi G, Kostic V, Potic J, Ruzicka E, Oertel W; German Competence Network on Parkinson's Disease. Eggert K, et al. Among authors: squillacote d. Mov Disord. 2010 May 15;25(7):896-905. doi: 10.1002/mds.22974. Mov Disord. 2010. PMID: 20461807 Clinical Trial.

Cite

Share